Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASA EFFECTS: Aspirin for Niaspan-Induced Flushing
NCT00626392Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Feb 2008
- Primary completion
- Apr 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin, sponsored by Abbott Laboratories. Started Feb 2008; status: completed.
02
Drugs
aspirin
Beyond the preview
Go deeper on NCT00626392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00626392.